Methyl 5-(4-cyanophenyl)isoxazole-3-carboxylate

Catalog No.: 
ACHBIX482
CAS No.: 
1375064-41-7
Molecular Formula: 
C12H8N2O3
Molecular Weight: 
228.21
Methyl 5-(4-cyanophenyl)isoxazole-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$266.00In stockInquiry
25g95%$1215.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-(4-cyanophenyl)isoxazole-3-carboxylate
IUPAC Namemethyl 5-(4-cyanophenyl)isoxazole-3-carboxylate
MDL No.MFCD22192328
Molecular FormulaC12H8N2O3
Molecular Weight228.21
SMILESO=C(C1=NOC(C2=CC=C(C#N)C=C2)=C1)OC
InChI KeyLQMGDMIENOPHGD-UHFFFAOYSA-N
SynonymMethyl 5-(4-Cyanophenyl)isoxazole-3-carboxylate;3-Isoxazolecarboxylic acid, 5-(4-cyanophenyl)-, methyl ester
CAS No.1375064-41-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACHBIX482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAIDX783 route compound structure diagram
    ACAIDX783517870-15-4In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACHBIX482 route product structure diagram
    ACHBIX4821375064-41-7In Stock
Inquiry

2. ACHBIX482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACCQAP562 route compound structure diagram
    ACCQAP5621375064-45-1In Stock
  4. Then
  5. ACHBIX482 route product structure diagram
    ACHBIX4821375064-41-7In Stock
Inquiry

3. ACHBIX482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHBIX482 route product structure diagram
    ACHBIX4821375064-41-7In Stock
Inquiry

Comments (0)